GlobeNewsWire
12 Jun 2026, 19:33 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Cosmos Health subsidiary Cana Laboratories received new contract manufacturing orders for 253,657 units of pharmaceutical products from Nassington and Verisfield. — New orders provide immediate revenue visibility and validate the company's manufacturing capabilities, though the scale of impact depends on the specific monetary value of these units.
+0.30Which stocks this story touches
The company received significant new contract manufacturing orders for over 250,000 units across multiple pharmaceutical products.
Continue reading
6 related stories
Top 2 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
6h ago
